Saar Gill Appointed PICI Co-Director

The Parker Institute for Cancer Immunology (PICI) has named Saar Gill, MBBS, PhD, FRACP, one of three co-directors. His appointment reflects PICI's commitment to leveraging leaders who excel in translating scientific discoveries into impactful patient treatments. Dr. Gill, who is known for his numerous contributions to cellular therapy and genetic engineering for blood cancers, embodies PICI's collaborative spirit and dedication to advancing immunotherapies to make all cancers curable.